APA (7th ed.) Citation

JC, T., YW, L., CY, H., CM, S., YT, W., T, K., . . . FY, L. (2026). REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice. Pharmaceutical research, 43(4), 1157. https://doi.org/10.1007/s11095-026-04065-9

Chicago Style (17th ed.) Citation

JC, Tsai, Lin YW, Huang CY, Shih CM, Wu YT, Kurosaki T, Inoue Y, Du YC, and Lin FY. "REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice." Pharmaceutical Research 43, no. 4 (2026): 1157. https://doi.org/10.1007/s11095-026-04065-9.

MLA (9th ed.) Citation

JC, Tsai, et al. "REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice." Pharmaceutical Research, vol. 43, no. 4, 2026, p. 1157, https://doi.org/10.1007/s11095-026-04065-9.